BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
5 | 1000.00 | 1002.75 | 63 |
24 | 997.75 | 1003.75 | 2 |
25 | 996.90 | 1004.60 | 2 |
5 | 996.65 | 1005.00 | 3 |
5 | 996.50 | 1008.00 | 40 |
0 | Total | Total | 0 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
5 | 1000.00 | 1002.75 | 63 |
24 | 997.75 | 1003.75 | 2 |
25 | 996.90 | 1004.60 | 2 |
5 | 996.65 | 1005.00 | 3 |
5 | 996.50 | 1008.00 | 40 |
0 | Total | Total | 0 |
Open | 1,014.00 |
Previous Close | 1,011.70 |
Volume | 43,545.00 |
Value (Lacs) | 435.36 |
VWAP | 1,003.34 |
Beta | |
Mkt Cap (Rs. Cr.) | 10,270 |
High | 1,019.60 |
Low | 996.10 |
UC Limit | 1,214.00 |
LC Limit | 809.40 |
52 Week High | 1,275.00 |
52 Week Low | 740.00 |
Face Value | 1.00 |
All Time High | 1,275.00 |
All Time Low | 295.00 |
20D Avg Volume | 480,085 |
20D Avg Delivery(%) | 13.04 |
Book Value Per Share | 70.57 |
Dividend Yield | 0.20 |
TTM EPS See historical trend | 14.61 (+22.89% YoY) |
TTM PE See historical trend | 68.43 (Average PE) |
P/B See historical trend | 14.17 (Average P/B) |
Sector PE | 47.37 |
*Delayed by 20 seconds.
Stock Score
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
3 out of 5 years Vijaya Diagnostic Centre has given negative returns in October.
Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
---|---|---|---|---|---|
October | 17.54% (2023) | 10.82% | -5.12% (2022) | -2.03% | 3.11% |
Vijaya Diagnost Standalone June 2025 Net Sales at Rs 174.85 crore, up 22.76% Y-o-Y Jul 29 2025 11:19 AM
Vijaya Diagnostic: Healthy show continues Jul 29 2025 09:27 AM
Vijaya Diagnostic Q1 FY26 Revenue Up 20.4% YoY to u20b91,880.5 Million Jul 28 2025 02:08 PM
Vijaya Diagnostic Board to Consider Q1 FY26 Results on July 28, 2025 Jul 18 2025 01:08 PM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 1170344 | Price 983.51 | % Traded 1.10 |
Qty 1170344 | Price 983.69 | % Traded 1.10 |
Qty 1180400 | Price 1029.06 | % Traded 1.19 |
Qty 1180400 | Price 1029.53 | % Traded 1.19 |
Qty 814594 | Price 1019.3 | % Traded 0.81 |
Qty 769580 | Price 1020.52 | % Traded 0.77 |
Qty 523967 | Price 1023.88 | % Traded 0.52 |
Qty 523967 | Price 1024.35 | % Traded 0.52 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Vijaya Diagnost | 999.80 | -1.18 | 10,270.44 | 71.06 | 14.34 | 17.23 | 1.07 | 135 | 627 | 0.00 |
Max Healthcare | 1,139.70 | 6.59 | 110,805.79 | 96.58 | 12.59 | 11.46 | 23.03 | 1,075 | 7,028 | 0.27 |
Apollo Hospital | 7,662.00 | 2.85 | 110,167.80 | 70.02 | 14.69 | 17.60 | 13.12 | 1,472 | 21,794 | 0.64 |
Fortis Health | 1,053.90 | 7.50 | 79,565.04 | 91.64 | 10.14 | 8.68 | 81.27 | 797 | 7,782 | 0.25 |
Global Health | 1,366.30 | 2.82 | 36,724.83 | 81.77 | 12.05 | 13.19 | 41.28 | 461 | 3,204 | 0.04 |